Representative Patents

PAT. NO. Title 11,207,326 Accelerated Treatment of COVID-19 and SAR’s Type Virus D936,507 Piezoelectric Acceleration Sensor D936,506 Piezoelectric Acceleration Sensor 11,111,376 Flame-Retarded Styrene-Containing Formulations 10,982,000 Methods for Treating and/or Reducing the Likelihood of Heart Failure by Administering Anti-Activin Receptor Type II (anti-ActRII) Antibody 10,940,090 Syringe Assembly D870,287 Prostheses D870,286 Prostheses D865,966 Knee Prosthesis D795,434 Knee…

Read More

Ann Pokalsky and Patricia Wilczynski Brozek give presentations at AIPLA’s webinar: “Focus on North America: Patent and Trademark Protection in Canada, the U.S. and Mexico.”

Ann Pokalsky and Patricia Wilczynski Brozek give presentations at AIPLA’s webinar: “Focus on North America: Patent and Trademark Protection in Canada, the U.S. and Mexico.” On April 15, 2020, Ann Pokalsky and Patricia Wilczynski Brozek, presented during AIPLA’s live webinar: “Focus on North America: Patent and Trademark Protection in Canada, the U.S. and Mexico.” They…

Read More

AIPLA webinar : “Inequitable Conduct after Regeneron”

AIPLA webinar : “Inequitable Conduct after Regeneron” Ann Pokalsky, a member of AIPLA’s Online Programs Committee, has coordinated a webinar entitled “Inequitable Conduct after Regeneron” to take place Thursday, June 7, 2018, at 12:30-2:00 p.m., ET. The webinar will be presented by Tom Irving, of Finnegan Henderson Farabow Garret & Dunner, LLP and David Hricik,…

Read More

U.S. Supreme Court Rules Inter Partes Review Proceedings do not Violate Article III or Seventh Amendment of the Constitution

U.S. Supreme Court Rules Inter Partes Review Proceedings do not Violate Article III or Seventh Amendment of the Constitution In a much-anticipated decision, the Supreme Court on Tuesday, April 24, 2018, held that inter partes review (IPR) proceedings do not violate Article III or the Seventh Amendment of the Constitution. Oil States Energy Services, LLC v. Greene’s Energy…

Read More

CAFC Rules Petitioner has Burden of Proof

CAFC Rules Petitioner has Burden of Proof to Demonstrate Unpatentability of Patent Owner’s Amended Claims in an Inter Partes Review On October 4, 2017, the U.S. Court of Appeals for the Federal Circuit (CAFC) sitting en banc, ruled that the petitioner has the burden of persuasion with respect to demonstrating unpatentability of amended claims proposed by…

Read More

Update on Regeneron Pharmaceuticals Inc. v. Merus N.V.

Update on Regeneron Pharmaceuticals Inc. v. Merus N.V. On Tuesday, September 12, 2017, as expected, Regeneron Pharmaceuticals Inc. petitioned  the Court of Appeals for the Federal Circuit (CAFC) for a rehearing en banc of its panel decision rendered in Regeneron Pharmaceuticals Inc. v. Merus N.V., 864 F3d 1343, 123 USPQ2d 1469 (Fed. Cir. 2017). On September 26, 2017, Washington…

Read More

CAFC Affirms Patent-in-Suit Unenforceable by Drawing an Adverse Inference of Intent to Deceive the USPTO During its Procurement

CAFC Affirms Patent-in-Suit Unenforceable by Drawing an Adverse Inference of Intent to Deceive the USPTO During its Procurement On July 27, 2017, in a panel decision, the Court of Appeals for the Federal Circuit (CAFC) affirmed the district court’s ruling below (Southern District of New York) that Regeneron’s US Patent No. 8,502,018 is unenforceable due…

Read More